P08631 (HCK_HUMAN) Homo sapiens (Human)

Tyrosine-protein kinase HCK UniProtKBInterProSTRINGInteractive Modelling

526 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

39 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of HIV-1 Nef-SF2 Core Domain in Complex with the Src Family Kinase Hck SH3-SH2 Ta… Heteromer
P03407;
80-242
MPD;IOD;
Assess
HIV-1 Nef protein in complex with engineered Hck-SH3 domain Heteromer
P03407;
79-138
Assess
HIV-1 NEF protein in complex with engineered HCK SH3 domain Heteromer
P03407;
79-138
EDO;
Assess
HIV-1 Nef protein in complex with engineered Hck-SH3 domain Heteromer
P03407;
80-138
Assess
HIV-1 Nef protein in complex with single domain antibody sdAb19 and an engineered Hck SH3 domain Heteromer
P03407;
81-136
Assess
Nef SF2 dimerization mutant bound to Hck SH3 Heteromer
P03407;
80-135
Assess
Crystal structure of SIVmac239 Nef bound to an engineered Hck SH3 domain Heteromer
Q5QGG3;
80-135
Assess
SRC FAMILY KINASE HCK SH3 DOMAINhomo-6-mer81-137
Assess
SRC FAMILY KINASE HCK-QUERCETIN COMPLEXhomo-2-mer79-526
CA;QUE;
Assess
Crystal structure of HCK kinase complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylp…homo-2-mer248-518
VSE;
Assess
SRC FAMILY KINASE HCK-AMP-PNP COMPLEXmonomer79-526
CA;ANP;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5…monomer81-526
OOQ;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5…monomer81-526
OOV;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5…monomer81-526
OOU;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-ethyl2-(((1r,4S)-4-(4-am…monomer81-526
OOO;
Assess
CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITORmonomer81-526
PP1;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1r,4S)-4-(4-amino-5…monomer81-526
OOS;
Assess
Src family kinase Hck with bound inhibitor A-641359monomer81-526
L3G;CA;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazi…monomer81-526
VSE;CA;CL;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-…monomer81-526
CA;CL;VRZ;
Assess
Src family kinase Hck with bound inhibitor A-420983monomer81-526
L1G;CA;
Assess
Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor tert-butyl {4-[4-amino-1-(p…monomer81-526
CA;CL;VSH;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-…monomer81-526
CA;CL;VSA;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 4-Amino-5-(4-phenoxyphenyl)-…monomer81-526
B43;CL;CA;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-…monomer81-526
VSB;CA;CL;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetra…monomer81-526
CA;CL;VSF;
Assess
Crystal Structure of HCK in complex with the fluorescent compound SKF86002monomer81-526
CA;SK8;GOL;CL;
Assess
Src family kinase Hck with bound inhibitor A-770041monomer81-526
L2G;CA;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5…monomer81-526
VSG;CA;
Assess
Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor N-[4-(4-amino-7-cyclopentyl-…monomer81-526
CA;CL;VS0;
Assess
Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1H-pyrrolo…monomer81-526
KS1;CA;CL;
Assess
Crystal Structure of HCK in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenox…monomer81-525
CA;VSE;CL;GOL;
Assess
Hck Kinase in Complex with Lck targetted Inhibitor PG-1009247monomer247-514
1BM;
Assess
Crystal structure of the SRC-family kinase HCK SH3-SH2-linker regulatory regionmonomer80-242
Assess
NMR ensemble of the uncomplexed human HCK SH2 domain, 20 structuresmonomer139-245
Assess
NMR Structure Analysis of the Hematopoetic Cell Kinase SH3 Domain complexed with an artificial high…monomer61-141
Assess
NMR Structure Analysis of the Hematopoetic Cell Kinase SH3 Domain complexed with an artificial high…monomer61-141
Assess
HUMAN HCK SH3 DOMAIN, NMR, MINIMIZED AVERAGE STRUCTUREmonomer78-138
Assess
HUMAN HCK SH3 DOMAIN, NMR, 25 STRUCTURESmonomer78-138
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3vs3.2.Amonomer0.8281-526
CA;VSE;99.33
Assess
1y57.1.Amonomer0.7681-524
62.84
Assess
4xi2.1.Amonomer0.7380-516
37.88
Assess
1opl.2.Amonomer0.71138-515
43.27
Assess

12 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23vs3.2.Amonomer0.8260-505
CA;VSE;99.33
Assess
Isoform 21y57.1.Amonomer0.7760-503
62.61
Assess
Isoform 21opl.2.Amonomer0.73117-496
42.30
Assess
Isoform 24xi2.1.Amonomer0.7359-495
37.88
Assess
Isoform 33vs6.1.Amonomer0.8259-504
VSH;99.33
Assess
Isoform 31y57.1.Amonomer0.7759-502
62.61
Assess
Isoform 34xi2.1.Amonomer0.7358-494
37.88
Assess
Isoform 31opl.2.Amonomer0.71116-493
44.88
Assess
Isoform 43vs3.2.Amonomer0.8280-525
CA;VSE;99.33
Assess
Isoform 41y57.1.Amonomer0.7680-523
62.61
Assess
Isoform 44xi2.1.Amonomer0.7379-515
37.88
Assess
Isoform 41opl.2.Amonomer0.71137-514
43.38
Assess